It has been shown previously that CD8b in vitro increases the range and the sensitivity of antigen recognition and in vivo plays an important role in the thymic selection of CD81 T cells. Consistent with this, we report here that CD81 T cells from CD8b knockout (KO) P14 TCR transgenic mice proliferate inefficiently in vitro. In contrast to these findings, we also show that CD8b KO mice mount normal CD8 primary, secondary and memory responses to acute infection with lymphocytic choriomeningitis virus. Tetramer staining and cytotoxic experiments revealed a predominance of CD8-independent CTL in CD8b KO mice. The TCR repertoire, especially the one of the TCRa chain, was different in CD8b KO mice as compared with B6 mice. Our results indicate that in the absence of CD8b, CD8-independent TCRs are preferentially selected, which in vivo effectively compensates for the reduced co-receptor function of CD8aa.
Introduction
Thymus-derived CD8+ TCRab+ T cells typically express heterodimeric CD8ab consisting of a disulfide-linked a and b chain (1) . CD8 can also be expressed as homodimeric CD8aa, namely on intra-epithelial T lymphocytes, some dendritic cells, NK, NKT and TCRcd+ T cells (2, 3) . Both forms of CD8 bind to the non-polymorphic domain of MHC class Ia molecules and associate via CD8a with the intracellular Src tyrosine kinase p56 lck (4) . On murine T cells, CD8b cannot be surface expressed in the absence of CD8a (5) . In vitro studies, mainly based on T cell hybridomas, have demonstrated that CD8b endows CD8 with efficient co-receptor function because it strengthens (i) the binding of MHC I-peptide to TCR, (ii) the association of CD8 with TCR, (iii) the partitioning of CD8 in lipid rafts and (iv) the association of CD8a with p56 lck and the linker of activation of T cells (6) (7) (8) (9) (10) (11) (12) .
In vivo, CD8b has been shown to play a critical role in thymic selection of CD8+ T cells; CD8b knockout (KO) mice have 3-to 5-fold lower numbers of mature CD8aa+ peripheral lymphocytes (13) (14) (15) . In contrast to these findings, it has been reported that CD8b KO mice mount normal primary cytotoxic CD8 responses upon acute viral infections (14) . Also cells from these mice exhibited normal cytotoxicity after in vitro stimulation with allogeneic splenocytes (13) . Even CD8a KO mice were shown to contain acute and chromic viral infections (16, 17) . In these mice, there was a strong bias to CD4+ T cells (13, 14, 16) . However, even MHC class II-deficient CD8a KO mice produced good cytotoxic T cell responses upon acute infection with lymphocytic choriomeningitis virus (LCMV) (16) . The objective of the present study was to elucidate why in these in vivo studies CD8b (and CD8a) was largely dispensable, while in previous in vitro studies, CD8b was found to greatly increase the sensitivity of antigen recognition by CD8+ T cells (6) (7) (8) (9) (10) (11) (12) . These striking differences might be explained by mechanisms that compensate for the reduced co-receptor activity of CD8aa in vivo. For example, the functional avidity of CD8+ T cells has been reported to depend on changes in cell membrane lipid raft composition and on the arrangements of TCR and CD8 (18, 19) . Alternatively, they could be explained by changes in the TCR repertoire. For example, the usage of TCR Vb chains in naive CD8a KO and C57BL/6 (B6) mice has been shown to be significantly different (16, 17) .
Furthermore, we wished to find out whether CD8b KO mice can generate normal CD8 memory and recall responses. Formation of primary effectors does not necessarily give rise to long-term functional CD8 memory (20, 21) . Memory development is programmed during T cell-antigen presenting cell interaction and depends on the quality and duration of the original antigenic stimulus (22, 23, 24) . Because CD8b affects TCR-MHC I-peptide interactions and TCR proximal signaling, it could also play a role in memory T cell formation. To address these questions, we used acute viral infections with LCMV, which elicit strong CD8 responses that have been extensively studied previously in B6 mice (24, 25, 28) . Major LCMV epitopes include the D b -restricted GP33- 41 (KAVYNFATC), nucleoprotein (NP)396-404 (FQPQNGQFI), GP276-306 (SGVENPGGYCL) and the K brestricted sub-dominant epitope NP205-212 (YTVKYPNL) (26) (27) (28) . The GP33-41 peptides can also be presented and recognized in the context of K b , although for optimal K b presentation the sequences 34-41 or 34-42 are superior (26, 27) . The Va2+ and Vb8.1+ P14 TCR recognizes GP33-41 in the context of D b and is expressed in the P14 TCR transgenic (Tg) mouse (29) .
We report that CD8b KO mice were able to generate strong anti-viral primary, secondary and memory CD8+ T cell responses. The poor co-receptor function of CD8aa was effectively compensated by selection and expansion of high avidity CD8-independent effector cells during LCMV infection.
Materials and methods

Mice and infections
Six-week-old C57BL/6 (B6) mice were purchased from Harlan (Horst, The Netherlands). CD8b KO mice were obtained from D. Littman and bred in the Institute's Animal Facility. To generate the P14 CD8b KO, P14 recombinase activating genes (RAG) KO, P14 CD8b KO RAG KO mice, P14 TCR transgenic and CD8b KO and/or RAG KO mice were crossed, intercrossed and the desired phenotype was conformed by simultaneous FACS analysis. Mice were infected intravenously (i.v.) with 200 PFU of LCMV strain WE (provided by C. Müller, University of Bern, Switzerland). Secondary GP33-specific responses were elicited by subcutaneous (s.c.) injection of 100 lg of GP33 peptide (KAVYNFATA)-conjugated virus-like particles (VLPs) (kindly provided by M. Bachmann, Cytos, Zü rich). Recall responses at day 4 were analyzed in the draining axillary and brachial lymph nodes. Naive mice were infected intra-nasally with 50 PFU of PR8 influenza A virus under anesthesia with isoflurane. Primary CD8+ T cell responses were examined 10 days after infection. All experiments involving animals were approved by the Cantonal Veterinary Office (Lausanne, Switzerland).
In vivo and in vitro cytotoxicity assays
In vivo cytotoxicity assay was performed as described previously (30) . Briefly, splenocytes from naive C57BL/6 mice were labeled with 1 or 0.1 lM of 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes, Eugene, OR, USA) and then pulsed with the indicated LCMV peptides (1 lM) and transferred i.v. (5 3 10 6 cells of each population) into groups of four mice each. Four hours later, lymphocytes were isolated from recipient's spleens. Labeled cells were distinguished from one another based on their different CFSE staining. The percent killing was calculated as follows: 1 À [({percentage of peptide pulsed in infected/ percentage of unpulsed in infected}/{percentage of peptide pulsed in uninfected/ percentage of unpulsed in uninfected}) 3 100]. For in vitro cytotoxicity assay, 51 Cr-labeled, D btransfected P815 cells (5 3 10 3 cells per well) were incubated for 30 min at 37°C with the indicated concentrations of GP33 (KAVYNFATA) peptide. After washing, target cells were incubated with splenocytes from LCMV-infected [8 days (d8)] CD8b KO or B6 mice, in presence or absence of 5 lg of anti-CD8a antibody (53-6.72). The effector to target cell ratio was adjusted to 30/1, considering as effectors D b loaded with GP33 peptide (D b -GP33) tetramer-positive splenocytes. After 4 h of incubation at 37°C, released 51 Cr was determined and the specific lysis calculated as follows: 100 3 [(experimental À spontaneous release)/(total À spontaneous release)].
Antibodies and tetramers
Production and binding studies with tetramers were performed essentially as described previously (30) . Briefly, LCMV effector or memory cells were incubated at 4°C for 60 min in FACS buffer (PBS supplemented with 1% FCS and 0.01% sodium azide) with 50 nM or the indicated concentrations of D b -GP33 or CD8-binding deficient D b Q226A, D227K-GP33 tetramers (31) . The following fluorescent anti-mouse mAbs were purchased from BD Biosciences: anti-CD8a 
Intracellular cytokine staining and peptides
Spleen or lymph node cells (3 3 10 6 ) were incubated in 96well round-bottom plates with 0.67 ll ml À1 of GolgiStop (BD Biosciences) in the presence or absence of 100 nM or the indicated concentrations of the LCMV peptides GP33 (KAVYNFATA), NP396 (FQPQNGQFI), GP276 (SGVENPG-GYCL) and NP205 (YTVKYPNL) for 6 h at 37°C. Cells were then permeabilized by incubation for 20 min in Cytofix-Cytoperm solution (BD Biosciences) and stained with anti-IFN-c antibody following the manufacturer's instructions.
In vitro proliferation assay
Lymph node and spleen cells from P14 RAG KO or P14 CD8b KO RAG KO TCR transgenic mice were pooled and incubated at 3 3 10 7 cells ml À1 with 10 lM CFSE (Molecular Probes) at 37°C for 10 min. Cells were then washed once with ice-cold DMEM (Invitrogen Life Technologies) containing 5% FCS, followed by two more washes in PBS. CFSElabeled cells were incubated with irradiated syngeneic B6 splenocytes previously pulsed (1 h at 37°C) with indicated concentrations of GP33 (KAVYNFATA) or Y4A (KAVANFATA) peptides. Proliferation was assessed by flow cytometry 72 h after the stimulation.
Results
Primary anti-LCMV responses in CD8b KO mice
To examine CD8+ T cell's ability to generate effector functions in the absence of CD8b, we compared LCMV-specific responses d8 after acute LCMV infection in CD8b KO and B6 mice. The frequencies of IFN-c-producing splenocytes from CD8b KO overall was comparable upon ex vivo stimulation with 100 nM of the D b -restricted GP33, NP396, GP276 and the K b -restricted NP205 peptides to those from B6 mice, although there were differences among the four epitopes ( Fig. 1A) . Because GP33-41 peptides can also bind to and be recognized in the context of K b (26, 27) , we assessed the IFN-c response of the splenocytes following incubations with P815 cells (H-2 d ) transfected with D b (P815-D b ) and pulsed with graded concentrations of GP33 peptide. The IFN-c response of B6 splenocytes was slightly higher in the range of 1-100 nM peptide as compared with CD8b KO cells ( Fig. 1B ). Because the inverse was true when using 100 nM of GP33-41 peptides in autologous presentation ( Fig. 1A) , a part of this IFN-c response was indeed K b restricted. This experiment also shows that differences in the IFN-c response were scant over a wide range of peptide concentrations.
The total numbers of IFN-c-producing splenocytes from CD8b KO mice overall were lower as compared with cells from B6 mice (Fig. 1C ). For the epitopes NP276 and NP205, the numbers of IFN-c-producing cells were 2-to 3-fold lower, but <2-fold lower for the NP396 and GP33 determinates. The total numbers of tetramer-positive cells were also lower in CD8b KO mice than in B6 mice. In the spleens of naive CD8b KO mice, CD8a+ T cells were ;3% and in B6 spleens 9%. Eight days after infection, the former expanded to ;36% and the latter to ;62%. Thus, on a per cell basis, the CD8+ T cells from CD8b KO mice exhibited at least as strong IFN-c responses as cells from B6 mice. Statistically, this is particularly significant for the GP276 and NP205 responses. At the peak of the LCMV infection, the expression of CD44, CD122 and CD62L was essentially the same in CD8b KO and B6 mice ( Fig. 1D ). Similar results were obtained when examining acute infections with influenza PR8. The proportions and total numbers of IFN-c-producing, D b -restricted, NP366-specific effector cells in bronchoalveolar lavages at the peak of the primary influenza response (day 10) were similar in B6 and CD8b KO mice (data not shown).
Eight days after LCMV infection, peptide-loaded target cells were lysed nearly as efficiently in CD8b KO as in B6 mice (Fig. 1E ). The modest reduction in killing in the case of NP276 was with high statistical significance smaller than the difference in the numbers of NP276 tetramer-specific cells (Fig. 1C ). This was also true in NP205 and with lesser statistical significance for NP396. Thus, CD8b-deficient effector cells clearly displayed unimpaired, if not increased, cytotoxicity in vivo. Taken collectively, these results indicate that the differentiation of functional effector cells was altered in subtle ways, but overall not impaired in CD8b KO mice. Our results are in accordance with the observation that splenocytes from LCMV-or vesicular stomatitis virus (VSV)-infected CD8b KO mice at the peak of the acute infection displayed ex vivo nearly the same anti-GP33 LCMV and anti-VSV cytotoxic responses as splenocytes from B6 mice (14) .
LCMV infection in CD8b KO mice elicits long-term functional CD8 memory
We next investigated the development of CD8 memory in CD8b KO mice. Their spleens were analyzed for virusspecific memory CD8+ T cells 3 months after LCMV infection. As assessed by intracellular IFN-c staining upon ex vivo stimulation with 100 nM peptide, slightly higher frequencies of GP33-and NP396-specific memory cells were found in CD8b KO mice than in B6 mice ( Fig. 2A ). This was also true when lower peptide concentrations were used for stimulation (data not shown). Conversely, for the GP276 and NP205 epitopes, the frequencies of IFN-c-responding memory cells were ;2-fold lower. The total numbers of IFN-c-producing cells in CD8b KO mice were equal or higher for the GP33 and NP396 and lower for the GP276 and NP205 epitopes ( Fig. 2B ), whereas the total number of tetramer-positive splenocytes was lower in CD8b KO mice for all epitopes (Fig. 2B ). These differences were statistically most significant for the GP276 and NP205 epitopes. The percentage of CD8+ splenocytes was ;18% for CD8b KO and B6 mice, but the absolute number was lower for CD8b KO mice (;1.2 3 10 7 versus 2.8 3 10 7 cells per spleen). Thus, on a per cell basis, the IFN-c response of CD8+ memory cells from CD8b KO mice was superior as compared with B6 mice. Consistent with this, we found that CD8b KO mice efficiently cleared LCMV, even when 10 times higher viral loads were used (Supplementary Figure S1 , available at International Immunology Online).
To further characterize the LCMV-specific CD8+ splenocytes, we examined the expression of cell surface markers that characterize memory CD8+ T cells. CD44, CD122 and CD127 were equally up-regulated on tetramer-positive cells from CD8b KO and B6 mice (Fig. 2C ). The up-regulation of the cytokine receptor chains CD122 and CD127 is a hallmark of long-term memory CD8+ T cells and was not affected by CD8b deficiency [ Fig. 2C and (32)]. Memory cells typically exhibit heterogeneous CD62L expression, corresponding to central and effector memory cell subsets, which was observed both on cells from CD8b KO and B6 mice. Both memory subsets were present at similar proportions in CD8b KO and wild-type (WT) mice [ Fig. 2C and (33)].
Another characteristic of CD8 memory T cells is their rapid in vivo cytotoxicity (34) . Memory CD8b KO cells exhibited 15-30% higher in vivo killing of autologous targets sensitized with each of the four LCMV epitopes (Fig. 2D ). Since the total numbers of the LCMV epitope-specific memory cells were lower in CD8b KO mice, this argues they had higher cytotoxicity than those of B6 mice. Taken together, these results demonstrate that the absence of CD8b did not impair the differentiation in and the functional integrity of long-lived memory CD8+ T cells following acute LCMV infection.
A hallmark of memory T cells is to mount rapid and strong recall responses. We therefore examined the recall responses 2 months after acute LCMV infection. To avoid interference by neutralizing antibodies, we used VLPs conjugated with the GP33 peptide (KAVYNFATA) to elicit GP33specific recall responses (35) . Four days after s.c. challenge with GP33-VLPs, the IFN-c response was measured in the draining lymph nodes. Higher proportions and absolute numbers of IFN-c-producing CD8+ T cells as well as D b -GP33 tetramer-positive cells were found in the lymph nodes of CD8b KO ( Fig. 3A and B ). This was explained, at least in part, by the higher initial number of GP33-specific memory cells in the lymph nodes of CD8b KO mice (Fig. 3B ). The relative expansion of IFN-c-producing and of D b -GP33 tetramer-binding cells of the recall response was similar in CD8b KO and B6 mice ( Fig. 3C ). GP33-VLPs also elicited primary anti-GP33 epitope-specific responses that were similar in CD8b KO and B6 mice (Fig. 3A) . Strong secondary GP33specific responses were also observed when CD8+ memory cells from CD8b KO mice were transferred into B6 mice, which were then infected with LCMV (data not shown). Interestingly, in the spleens, the frequency of GP33-specific CD8+ T cells was higher in B6 than in CD8b KO mice, while in the lymph nodes, the inverse was true (Figs 1-3 and data not shown). Taken collectively, these results demonstrate that the long-lived memory CD8+ T cells in CD8b KO mice were capable to efficiently expand and to produce IFN-c upon challenge by GP33-VLPs or by LCMV infection.
GP33-specific CTL from CD8b KO mice are CD8 independent
The findings that CD8b is dispensable for CD8 T cell responses in vivo is at odds with previous in vitro studies, indicating that CD8b broadens the range and increases the sensitivity of antigen recognition (6) (7) (8) (9) (10) (11) (12) . To investigate this divergence, we assessed the cytolytic activity of splenocytes from CD8b KO and B6 mice d8 after LCMV infection. Cells from B6 mice efficiently killed sensitized P815-D b targets (Fig. 4A ). Half-maximal lysis was slightly below 10 À10 M GP33 peptide. By contrast, CD8-binding deficient P815-D b 226/227 targets were killed inefficiently and half-maximal lysis required an ;100-fold higher peptide concentration (Fig. 4A) . Conversely, splenocytes from CD8b KO mice killed P815-D b targets as efficiently as splenocytes from B6 mice, and half-maximal lysis required only slightly higher peptide concentration (Fig. 4B) . Remarkably, however, CD8b KO splenocytes killed P815-D b 226/227 targets nearly as efficiently as P815-D b targets. Essentially, the same results were obtained when P815-D b targets were used in the absence or presence of the CD8a-blocking antibody 53.6.72 ( Fig. 4C and D) . Taken together, these results demonstrate that the cytotoxic response of GP33-specific CTL from CD8b KO mice was CD8 independent, whereas the one from B6 mice was CD8 dependent.
We next examined the binding of D b -GP33-41 and D b mutant at residues 226 and 227 loaded with GP33 peptide (D b 226/227-GP33)-41 tetramers to splenocytes from CD8b KO and B6 mice d8 after LCMV infection. D b -GP33 tetramer bound to CD8b KO splenocytes more efficiently than to B6 splenocytes ( Fig. 4E and F) . The higher maximal binding on CD8b KO splenocytes may be explained, at least in part, by the fact that GP33-specific splenocytes from CD8b KO mice expressed more TCRs than those B6 mice (mean fluorescence intensity after staining with PE-labeled anti-TCR mAb H57 was 1419 versus 1192). Half-maximal binding of D b -GP33 tetramer to cells from CD8b KO mice required about four times lower concentration as compared with cells from B6 mice. Remarkably, while the D b 226/227-GP33-41 tetramer bound to CD8b KO cells nearly as efficiently as the D b -GP33 tetramer, it very poorly stained B6 splenocytes (Fig. 4E ). Taken collectively, these results indicate that GP33-specific CD8+ effector cells from CD8b KO mice are CD8 independent in terms of target cell killing and tetramer binding, whereas those from B6 mice rely for both on CD8 co-engagement.
CD8b deficiency alters the TCR repertoire
We next examined whether the difference in CD8 dependence of GP33-specific CTL in B6 and CD8b KO splenocytes was related to differences in the TCR repertoire. First, we assessed the TCR Vb usage of D b -GP33 tetramer+ CD8+ T cells by means of anti-Vb mAb and flow cytometry. Eight days after LCMV infection, tetramer+ splenocytes from CD8b KO mice exhibited a nearly 10-fold higher percentage of Vb8.3+ T cells than those from B6 mice (Fig. 5A ). Smaller differences were observed for other Vb. For example, Vb6+ T cells were slightly more frequent in the spleens of CD8b KO mice as compared with those of B6 mice. The inverse was true for Vb 7, 8.1, 8.2, 9, 10 and 11+ cells. These differences were also visible on total CD8a+ T cells from d8 LCMV immune mice, albeit less pronounced and with low statistical significance (Fig. 5B ). This is expected because the CD8 response to acute anti-LCMV infection is highly diverse and the D b -GP33-specific response constitutes only a fraction (26) . The same analysis performed on d80 LCMV immune cells showed the same and additional differences, such as significant skewing of the usage of Vb5.1.2 and Vb7. By contrast, in total CD8a+ T cells no marked differences in Vb usage were noticed between CD8b KO mice and B6 mice (Fig. 5B) .
We then performed the same analysis with anti-Va-specific mAb, which was limited, because only four antibodies were available. On the total CD8a+ T cells from naive B6 and CD8b KO mice, the proportion of Va2+ cells was remarkably high (9-10%), followed by Va8 (6-7%). The differences in the usage of Va2, Va3.2, Va8 and Va11.2 were statistically significant, but modest (10-20%) (Fig. 5C ). To find out whether differences were obscured by high diversity, we repeated this experiment by gating on CD8a+ T cells expressing Vb7 or 8.3. Clear differences between B6 and CD8b KO mice thus became visible. For example, in CD8+ splenocytes from CD8b KO, Vb7+ T cells expressed 30-40% more Va2 (P = 0.02) and Va8 (P = 0.08), whereas Vb8.3 splenocytes exhibited more Va8 (P = 0.0001).
A similar scenario was observed when analyzing D b -GP33-specific CD8a+ T cells from d8 LCMV immune mice. D b -GP33+ CD8a+ T cells from CD8b KO and B6 mice expressed 26-30% Va2, but only 3-7% of Va3.2, Va8 and Va11.2 (Fig. 5E ). The differences in expression of these Va between CD8b KO and B6 cells were small and statistically barely significant. Again, considerably larger differences were seen when the D b -GP33 tetramer+ cells were gated on Vb6-, 7-or 8.3-expressing cells (Fig. 5F ). For example, Vb6+ cells from B6 mice expressed about five times more Va2 than cells from CD8b KO mice (P = 0.013). Similarly, Vb8.3+ cells from B6 mice expressed nearly 2-fold more Va2 than cells from CD8b KO mice (P = 0.003) and Vb7+ from B6 mice two times less Va8 than cells from CD8b KO mice (P = 0.02). Taken together, these results demonstrate that there are clear and statistically significant differences in the TCR repertoire in B6 versus CD8b KO mice. For the TCRb chains, differences in Vb usage were notable only on CD8+ effector and memory cells and especially on D b -GP33specific CTL. For the TCRa chains, statistically significant differences in Va usage were seen on naive as well as on D b -GP33-specific effector cells only when gating on subpopulations expressing given Vb, which suggests highly diverse TCRa chain repertoires in both mice.
In order to assess the role of CD8b in a setting where only one defined TCR is available, we crossed CD8b KO and P14 TCR Tg mice. As reported previously, splenocytes and lymph node cells from P14 TCR Tg mice were predominantly D b -GP33 tetramer+ (97%) and expressed the Tg Va2+ TCRa chain and the Vb8.1+ TCRb chain [ Fig. 6A and (29) ]. Remarkably, CD8b-deficient P14 TCR Tg mice (P14 3 CD8b KO) predominately expressed also the Tg Vb8.1 TCRb chain, but variable levels of the Va2+ Tg TCRa chain. The expression of Va2 and D b -GP33 tetramer staining correlated, arguing that in P14 3 CD8b KO mice diverse endogenous TCRa chains were co-expressed at various levels with the Tg P14 TCRa chain and that the tetramer binding was mediated primarily by the Tg P14 TCR. Moreover, in striking contrast to P14 TCR Tg mice, in P14 3 CD8b KO mice nearly half of the D b -GP33 tetramer+ cells were CD4+ ( Fig. 6A and B) . The total number of CD8+ lymph node cells in P14 mice was ;2-fold higher than in P14 3 CD8b KO, i.e. a smaller difference when compared with B6 and CD8b KO mice (Supplementary Figure S2A , available at International Immunology Online). The total cell numbers in lymph nodes (and spleen) were comparable in P14 and P14 3 CD8b KO, which is to a large extent explained by compensatory Figure S2A and B, available at International Immunology Online).
When the P14 3 CD8b KO mice were bred to RAG KO animals (P14 3 CD8b KO 3 RAG KO), these CD4 cells disappeared ( Fig. 6B) . They also disappeared when P14 3 CD8b KO mice were bred on MHC class II KO (data not shown). Moreover, cells from P14 3 CD8b KO 3 RAG KO mice expressed only the Tg P14 TCR (Fig. 6A and B) . These findings indicate that in P14 3 CD8b KO, but not in P14 TCR Tg mice, endogenous TCRa chains are extensively rearranged.
CD8b promotes the proliferation of CD8a+ T cells from P14 TCR Tg mice
To assess the role of CD8b in the activation of cells expressing only one TCR, we assessed the in vitro proliferation of splenocytes from RAG-deficient P14 TCR Tg and P14 3 CD8b KO mice. As assessed by CFSE labeling, 72 h after incubation with graded concentrations of GP33-41 peptides, the proliferation of CD8b-deficient cells exhibited impaired proliferation, especially at low peptide concentrations (Fig.  6C) . The difference became striking, when the weak agonist peptide GP33-41 Y4A was used for stimulation. While the cells from P14 TCR Tg mice efficiently proliferated already at 0.1 nM, CD8b-deficient cells significantly proliferated only at >100 nM peptide (Fig. 6D) . These results are consistent with the reported ability of CD8b to increase the range and the sensitivity of antigen recognition (6) (7) (8) (9) (10) (11) (12) and argue that the remarkably efficient anti-viral responses in CD8b KO mice are related to changes in the TCR repertoire.
Discussion
The present study provides detailed evidence demonstrating that CD8b KO mice upon acute LCMV infection mount primary CD8+ T cell responses that overall are equivalent to those of B6 mice (Fig. 1 ). This is in accordance with a previous study showing that CD8b KO mice generate normal cytotoxic responses upon acute infection with LCMV and VSV (14) . Our study further indicates that the numbers of total and LCMV epitope-specific CD8a+ splenocytes from infected CD8b KO mice were significantly lower as compared with those from B6 mice (Fig. 1A ). This demonstrates that on a per cell basis, the anti-LCMV-specific cells from CD8b KO mice were actually more reactive than those from B6 mice. Even CD8a KO mice have been shown to mount efficient primary T cell responses upon infection with LCMV and polyoma virus, respectively (16, 17) . In addition, our study shows for the first time that CD8b KO mice also form long-lasting, functional CD8 memory and recall responses, indicating that in vivo CD8b is dispensable for the differentiation of bona fide CD8 memory cells, as well as their activation in vivo and in vitro. (Figs 2 and 3 , G. S. Angelov and I. F. Luescher, unpublished results).
These findings are at variance with numerous previous in vitro studies demonstrating that CD8b increases the sensitivity and the range of antigen recognition (6) (7) (8) (9) (10) (11) (12) . Our observation that splenocytes from CD8b-deficient P14 TCR Tg mice proliferated far less well than those from P14 TCR Tg mice is consistent with these studies. A key difference between these two sets of studies is that in the former strong polyclonal CD8+ T cell responses were investigated and in the latter monoclonal T cell responses. Although we cannot rule out that there may be compensatory mechanisms that allow CD8a+ T cells to adapt for the lesser co-receptor activity of CD8aa in vivo, several observations argue that these divergent findings are primarily explained by differences in T cell specificities. (i) There were subtle, but significant, differences in the anti-viral CD8 responses in B6 and CD8b (and CD8a) KO mice when analyzing different epitopes (Figs 1 and 2, unpublished results and 16, 17 ). This argues against putative compensatory mechanisms, which one would expect not to be epitope specific. (ii) There were clear differences in the repertoire of TCRb chains in virus-infected B6, CD8b (and CD8a) KO mice ( Fig. 5A and B and 16, 17 ). (iii) In virus-infected CD8b (and CD8a) KO mice, CD8independent CTL were clearly dominant. For example, target cell killing by GP33-specific CTL from B6 mice was severely inhibited by blocking anti-CD8 antibodies or by CD8-binding ablating mutations of D b , whereas those from CD8b KO mice were not ( Fig. 4A-D) . The CD8-independent nature of the CTL from CD8b KO mice was also evident from our tetramer-binding studies, showing that GP33-specific CTL from CD8b KO mice bound D b 226/227-GP33 tetramer as efficiently as D b -GP33 tetramer, whereas CTL from B6 mice efficiently bound only the latter tetramer ( Fig. 4E and F) .
It is interesting to note that D b -GP33 tetramer bound to splenocytes from d8 LCMV-infected mice from CD8b and CD8a KO mice more avidly than to cells from B6 mice [ Fig.  4E and F and ref. (16) ]. This is consistent with the prevailing view that CD8-independent TCRs typically have high affinity and hence can efficiently bind cognate MHC I-peptide complexes also without the avidity-enhancing effect of CD8 (36) . It should be noted, however, that the differences in functional (i.e. half-maximal lysis) and physical avidity (i.e. D b -GP33 tetramer binding) between GP33-specific CTL from B6 and CD8b KO mice are modest. More striking differences were observed when CD8-binding deficient target cells and tetramers were used (Fig. 4) , indicating that CTL from CD8b KO mice in addition to having an increased avidity also are less CD8 dependent. It has been shown that CD8 dependence can be an intrinsic property of TCR and not of the T cell expressing it and that there exist CD8-independent TCRs that have low or moderate affinity for their cognate ligands (37) . One explanation for this is that CD8-independent TCRs bind their ligands in an orientation that disfavors efficient coengagement of CD8 for steric reasons (38) .
CD8b has been shown to play an important role in the thymic selection of CD8+ T cells (13) (14) (15) 39) . Similar, albeit less mice were incubated in vitro for 72 h with the indicated concentrations of GP33-41 peptides (KAVYNFATA). The proliferation of CD8+ T cells was assessed by flow cytometry. The bars indicate the proportion of undivided cells. One out of three experiments is shown. (D) The experiment was repeated using the weak peptide agonist GP33-41 Y4A (KAVANFATA). One out of two experiments is shown. severe, effects were observed in mice expressing tailless CD8b (40) . Remarkably, the impact of disruption of the CD8b gene or over-expression of tailless CD8b on thymic selection seems to depend on the Tg TCR that is used. For example, CD8 single-positive (SP) T cells were barely selected in CD8b-deficient H-Y TCR Tg mice (13) . The selection of H-Y TCR + CD4 À CD8+ thymocytes was also strongly compromised in mice expressing tailless CD8b, whereas the selection of F5 TCR Tg CD8+ thymocytes was not (40) . We found that in P14 TCR transgenic mice, CD8b deficiency caused only a 2-to 3-fold reduction of peripheral CD8+ T cells (Fig. 6A and B and Supplementary Figure S2A , available at International Immunology Online). These findings argue that CD8b deficiency (or taillessness) affects the thymic selection of CD8+ T cells expressing CD8-dependent TCR more than those expressing CD8-independent TCR. This would imply that the TCR repertoire in naive CD8b KO mice is skewed toward CD8-independent specificities, i.e. should contain more CD8-independent CD8+ T cells than WT mice. This view is consistent with the marked differences observed in the TCRb chain repertoire of naive B6 and CD8a KO mice (16, 17) . On splenocytes from naive CD8b KO and B6 mice, we observed only scant differences in the TCR Vb usage (Fig.  5B ). However, if the diversity of the TCRb chain repertoire in CD8b KO mice was similarly large as reported for B6 mice, our crude analysis would be prone to miss differences (25, 41) .
Our results strongly suggested that the TCRa chain repertoire in CD8b KO and B6 mice is large because strong differences in TCR Va usage became only apparent after gating on given Vb (Fig. 5C-F ). Moreover and importantly, disruption of the CD8b gene seems to strongly impact on the TCRa chain repertoire. Rearrangement of TCRa chains takes place on double-positive (DP) thymocytes and is terminated when a newly formed TCR together with CD8 provides a signal upon recognition of MHC I-peptide ligands on the thymic epithelium (39, 42, 43) . Compromising CD8 by deletion of CD8b can be expected to impede this TCRab selection and therefore TCRa chain rearrangement to continue, until a TCR is formed that can provide a signal with CD8aa. This view is supported by several converging evidences, such as the following: (i) in CD8b-deficient, but not in normal, P14 TCR Tg mice, a high proportion of CD8+ T cells expressed in addition to the Tg P14 TCRa chain rearranged endogenous TCRa chains ( Fig. 6A and B) . These endogenously rearranged TCRa chains allowed selection of CD4+ T cells, expressing various levels of P14 TCR (Fig. 6A and  B) . (ii) The message for RAG1 in DP thymocytes from P14 3 CD8b KO mice was ;10-fold higher than in DP thymocytes from P14 Tg mice (unpublished data). (iii) Due to hampered TCRab selection in CD8b KO and to a lesser extent in P14 3 CD8b KO mice, the numbers of CD8 SP thymocytes and CD8+ T cells were reduced and those of CD4 SP thymocytes and CD4+ T cells increased (Supplementary Figure S2A , available at International Immunology Online).
Moreover, several observations argue that in CD8b (and CD8a) KO mice, TCRs of different affinities and sequences are selected and expanded upon viral infections than in B6 mice. For example, it has been demonstrated that high affinity MHC I-peptide ligands negatively select DP thymocytes in OT-1 TCR Tg mice, but positively select in CD8a-deficient OT-1 mice (42) . This argues that CD8ab lowers the affinity requirements for thymic selection, i.e. that in the absence of CD8b (and CD8a) the affinity windows for positive and negative selection are shifted to higher affinities (16, 44) . This view is supported by the findings that (i) CD8b (and CD8a) KO and B6 mice exhibited differences in TCR repertoires of naive and virus-specific effector T cells ( Fig. 5A-D, 16, 17) and (ii) GP33-specific CTL in CD8b (and CD8a) KO mice bound D b -GP33 tetramer more avidly than CTL from B6 mice ( Fig. 4E and F, 16) .
Taken collectively, the present study demonstrates that CD8b KO mice can generate highly reactive primary, secondary and memory CD8+ T cell responses upon acute viral infections. It provides evidence that CD8b deficiency impacts on the TCRa chain rearrangement and the selection of the TCR repertoire, which allows preferential selection and expansion of CD8-independent TCR upon viral infection, which effectively compensates for the reduced co-receptor function of CD8aa.
